Literature DB >> 9865903

Comparison of features of human breast cancer cell lines and their corresponding tumors.

I I Wistuba1, C Behrens, S Milchgrub, S Syed, M Ahmadian, A K Virmani, V Kurvari, T H Cunningham, R Ashfaq, J D Minna, A F Gazdar.   

Abstract

Although human tumor-derived cell lines play an important role in the investigation of cancer biology and genetics, there is no comprehensive study comparing tumor cell line properties with those of the individual tumors from which they were derived. We compared the properties of a series of 18 human breast cancer cell lines that were cultured for a median period of 25 months (range, 9-60 months) and their corresponding archival tumor tissues. We compared morphological characteristics, ploidy, and immunohistochemical expression of estrogen receptors, progesterone receptors, and HER2/neu and p53 proteins. For 17 of these cases, we also tested for allelic losses at 18 chromosomal regions frequently deleted in breast tumors using 51 polymorphic microsatellite markers, and we determined the TP53 gene mutation status in exons 5 to 10. There was an excellent correlation between the breast tumor cell lines and their corresponding tumor tissues for morphological features (100%); presence of aneuploidy (87%); immunohistochemical expression of estrogen receptors (87%), progesterone receptors (73%), and HER2/neu (93%) and p53 proteins (100%); allelic loss at all of the chromosomal regions analyzed (82-100% concordance); and TP53 gene mutations (75%). The same parental allele was lost in 279 (99%) of 281 of the comparisons of allelic losses. The fractional allelic loss indices (a reflection of the total allelic loss) of the cell lines and their corresponding tumor tissues were identical or similar in 15 (88%) of 17 paired comparisons. Although our previous studies (A. Gazdar et al., Int. J. Cancer, in press) indicated that only a subset of primary breast carcinomas that have several features indicative of advanced tumors with poor prognosis can be successfully cultured, the cell lines retain the properties of their parental tumors for lengthy culture periods and, thus, provide suitable model systems for biomedical studies.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9865903

Source DB:  PubMed          Journal:  Clin Cancer Res        ISSN: 1078-0432            Impact factor:   12.531


  33 in total

1.  High-resolution chromosome 3p allelotyping of breast carcinomas and precursor lesions demonstrates frequent loss of heterozygosity and a discontinuous pattern of allele loss.

Authors:  A Maitra; I I Wistuba; C Washington; A K Virmani; R Ashfaq; S Milchgrub; A F Gazdar; J D Minna
Journal:  Am J Pathol       Date:  2001-07       Impact factor: 4.307

Review 2.  Lung cancer cell lines: Useless artifacts or invaluable tools for medical science?

Authors:  Adi F Gazdar; Boning Gao; John D Minna
Journal:  Lung Cancer       Date:  2010-01-15       Impact factor: 5.705

3.  X-linked ectodermal dysplasia receptor is downregulated in breast cancer via promoter methylation.

Authors:  Vasu Punj; Hittu Matta; Preet M Chaudhary
Journal:  Clin Cancer Res       Date:  2010-02-09       Impact factor: 12.531

4.  Integrated proteomic profiling of cell line conditioned media and pancreatic juice for the identification of pancreatic cancer biomarkers.

Authors:  Shalini Makawita; Chris Smith; Ihor Batruch; Yingye Zheng; Felix Rückert; Robert Grützmann; Christian Pilarsky; Steven Gallinger; Eleftherios P Diamandis
Journal:  Mol Cell Proteomics       Date:  2011-06-07       Impact factor: 5.911

5.  Mitochondrial and plasma membrane lactate transporter and lactate dehydrogenase isoform expression in breast cancer cell lines.

Authors:  Rajaa Hussien; George A Brooks
Journal:  Physiol Genomics       Date:  2010-12-21       Impact factor: 3.107

6.  A Phase I Study of the AKT Inhibitor MK-2206 in Combination with Hormonal Therapy in Postmenopausal Women with Estrogen Receptor-Positive Metastatic Breast Cancer.

Authors:  Cynthia X Ma; Cesar Sanchez; Feng Gao; Robert Crowder; Michael Naughton; Timothy Pluard; Allison Creekmore; Zhanfang Guo; Jeremy Hoog; A Craig Lockhart; Austin Doyle; Charles Erlichman; Matthew J Ellis
Journal:  Clin Cancer Res       Date:  2016-01-18       Impact factor: 12.531

7.  Variable levels of chromosomal instability and mitotic spindle checkpoint defects in breast cancer.

Authors:  Dae-Sung Yoon; Robert P Wersto; Weibo Zhou; Francis J Chrest; Elizabeth S Garrett; Teag Kyu Kwon; Edward Gabrielson
Journal:  Am J Pathol       Date:  2002-08       Impact factor: 4.307

8.  Inferring predominant pathways in cellular models of breast cancer using limited sample proteomic profiling.

Authors:  Yogesh M Kulkarni; Vivian Suarez; David J Klinke
Journal:  BMC Cancer       Date:  2010-06-15       Impact factor: 4.430

9.  Cellular and molecular phenotypes of proliferating stromal cells from human carcinomas.

Authors:  E P Kopantzev; N A Vayshlya; M R Kopantseva; V I Egorov; M Pikunov; M V Zinovyeva; T V Vinogradova; I B Zborovskaya; E D Sverdlov
Journal:  Br J Cancer       Date:  2010-04-20       Impact factor: 7.640

10.  Molecular profiling of breast cancer cell lines defines relevant tumor models and provides a resource for cancer gene discovery.

Authors:  Jessica Kao; Keyan Salari; Melanie Bocanegra; Yoon-La Choi; Luc Girard; Jeet Gandhi; Kevin A Kwei; Tina Hernandez-Boussard; Pei Wang; Adi F Gazdar; John D Minna; Jonathan R Pollack
Journal:  PLoS One       Date:  2009-07-03       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.